Clinical Chemistry and Laboratory Medicine

Article	Citations
Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests	117
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors	72
ChatGPT, critical thing and ethical practice	69
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid	64
Evaluation of the automated LIAISON® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies	62
IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2	57
Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers	56
Potentials and pitfalls of ChatGPT and natural-language artificial intelligence models for the understanding of laboratory medicine test results. An assessment by the European Federation of Clinical C	53
Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR	51
Why C-reactive protein is one of the most requested tests in clinical laboratories?	49
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers	46
The European Biological Variation Study (EuBIVAS): a summary report	46
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine	45
IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection	44
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis	44
Interferences in immunoassays: review and practical algorithm	42
Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders	41
Performance specifications for measurement uncertainty of common biochemical measurands according to Milan models	40
Monocyte distribution width (MDW) parameter as a sepsis indicator in intensive care units	40
Artificial intelligence in clinical applications for lung cancer: diagnosis, treatment and prognosis	40
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series	40
Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows	39
The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federatio	39
Blood lactate concentration in COVID-19: a systematic literature review	38
Clinical relevance of biological variation of cardiac troponins	38

Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma	36
IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients	35
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	35
Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?	34
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays	34
Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19	33
Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients	32
Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients	30
Simultaneous measurement of 13 circulating vitamin D3 and D2 mono and dihydroxy metabolites using liquid chromatography mass spectrometry	30
The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus	30
Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay	30
Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)	29
The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors	29
High-sensitivity cardiac troponins in pediatric population	29
Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis	29
The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study	28
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer	28
Benefits, limitations and controversies on patient-based real-time quality control (PBRTQC) and the evidence behind the practice	27
Biological variation of serum neurofilament light chain	27
Artificial intelligence in laboratory medicine: fundamental ethical issues and normative key-points	26
Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis	26
European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants	26
Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS	26
Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants	25
Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1	25
Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients	25
Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort	25
Self-sampling at home using volumetric absorptive microsampling: coupling analytical evaluation to volunteers’ perception in the context of a large scale study	25
The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications	24
Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine	24
Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnostics	24
Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs	23
Saliva – a new opportunity for fluid biopsy	23
The underestimated issue of non-reproducible cardiac troponin I and T results: case series and systematic review of the literature	22
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay	22
Within- and between-subject biological variation data for tumor markers based on the European Biological Variation Study	22
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper	22
A biological profile for diagnosis and outcome of COVID-19 patients	22
D-dimer: old dogmas, new (COVID-19) tricks	21
Editorial and Executive Summary: IFCC Interim Guidelines on Clinical Laboratory testing during the COVID-19 Pandemic	21
Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination	21
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro-Diagnostics Regulation	21
An approach for determining allowable between reagent lot variation	21
Protease-antiprotease imbalance in patients with severe COVID-19	20
Prognostic role of Krebs von den Lungen-6 (KL-6) measurement in idiopathic pulmonary fibrosis: a systematic review and meta-analysis	20
How is test laboratory data used and characterised by machine learning models? A systematic review of diagnostic and prognostic models developed for COVID-19 patients using only laboratory data	20
Comparability of 11 different equations for estimating LDL cholesterol on different analysers	20
A new tool for sepsis screening in the Emergency Department	20
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?	20
Cytokine “storm”, cytokine “breeze”, or both in COVID-19?	20

Mechanism of bilirubin elimination in urine: insights and prospects for neonatal jaundice	19
Implementation of the new EU IVD regulation – urgent initiatives are needed to avert impending crisis	19
Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups	19
Where is laboratory medicine headed in the next decade? Partnership model for efficient integration and adoption of artificial intelligence into medical laboratories	19
Flowing through laboratory clinical data: the role of artificial intelligence and big data	18
Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort	18
Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?	18
Lot-to-lot reagent verification: challenges and possible solutions	18
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study	18
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference	18
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency	17
Biological variation estimates of thyroid related measurands – meta-analysis of BIVAC compliant studies	17
Personalized reference intervals – statistical approaches and considerations	17
Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis	17
Biological variation: recent development and future challenges	17
Laboratory medicine in the COVID-19 era: six lessons for the future	17
Ageing, ACE2 deficiency and bad outcome in COVID-19	16
Serum GFAP – reference interval and preanalytical properties in Danish adults	16
Quality indicators in laboratory medicine: state-of-the-art, quality specifications and future strategies	16
Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis	16
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections	16
Redesigning the surveillance of in vitro diagnostic medical devices and of medical laboratory performance by quality control in the traceability era	16
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals	16
Definition and application of performance specifications for measurement uncertainty of 23 common laboratory tests: linking theory to daily practice	16
High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials	16
Optimizing hepcidin measurement with a proficiency test framework and standardization improvement	16
Health Technology Assessment to assess value of biomarkers in the decision-making process	16
Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity?	15
Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry	15
Metrological traceability and clinical traceability of laboratory results – the role of commutability in External Quality Assurance	15
Critical review and meta-analysis of biological variation estimates for tumor markers	15
Using machine learning to identify clotted specimens in coagulation testing	15
A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers	15
An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of aldosterone in human serum and plasma	15
Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance	15
Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP	15
Analytical assessment of ortho clinical diagnostics high-sensitivity cardiac troponin I assay	15
Intra- and inter-cycle variability of anti-Müllerian hormone (AMH) levels in healthy women during non-consecutive menstrual cycles: the BICYCLE study	15
An original multiplex method to assess five different SARS-CoV-2 antibodies	15
Harmonization status of procalcitonin measurements: what do comparison studies and EQA schemes tell us?	15
How to meet ISO15189:2012 pre-analytical requirements in clinical laboratories? A consensus document by the EFLM WG-PRE	15
Traceable machine learning real-time quality control based on patient data	15
A new door to a different world: opportunities from the metaverse and the raise of meta-medical laboratories	15
From big data to better patient outcomes	15
Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer	15
Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio	15
Reference values for plasma neurofilament light chain in healthy Chinese children	14
Critical appraisal and meta-analysis of biological variation estimates for kidney related analytes	14
Using artificial intelligence in a primary care setting to identify patients at risk for cancer: a risk prediction model based on routine laboratory tests	14
Report from the HarmoSter study: impact of calibration on comparability of LC-MS/MS measurement of circulating cortisol, 17OH-progesterone and aldosterone	14
Reference values for plasma neurofilament light chain (NfL) in healthy Chinese	14
Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays	14
Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis	14
Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients	14
Distribution of HOMA-IR in a population-based cohort and proposal for reference intervals	14
The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria	14
High-sensitivity assay for cardiac troponins with POCT methods. The future is soon	14
Multi-omics analysis from archival neonatal dried blood spots: limitations and opportunities	13
Reference values of trace elements in blood and/or plasma in adults living in Belgium	13
Performance of digital morphology analyzer Vision Pro on white blood cell differentials	13
Cardiac troponin measurement at the point of care: educational recommendations on analytical and clinical aspects by the IFCC Committee on Clinical Applications of Cardiac Bio-Markers (IFCC C-CB)	13
Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug mon	13
Common laboratory tests as indicators of COVID-19 severity on admission at high altitude: a single-center retrospective study in Quito (ECUADOR)	13
Complex analytical procedures in diagnostic laboratories and the IVDR	13
Monocyte distribution width (MDW): a useful biomarker to improve sepsis management in Emergency Department	13
Developing a machine learning prediction algorithm for early differentiation of urosepsis from urinary tract infection	13
Method evaluation in the clinical laboratory	13
Global FT4 immunoassay standardization: an expert opinion review	13
Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group	13
Automated prediction of low ferritin concentrations using a machine learning algorithm	13
The clinical laboratory: a decision maker hub	13
The multicenter European Biological Variation Study (EuBIVAS): a new glance provided by the Principal Component Analysis (PCA), a machine learning unsupervised algorithms, based on the basic metabolic	12
Using machine learning to develop an autoverification system in a clinical biochemistry laboratory	12
Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model	12
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection	12
Comparison of the analytical performance of the PATHFAST high sensitivity cardiac troponin I using fresh whole blood vs. fresh plasma samples	12
Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs	12
Isotope dilution LC-MS/MS quantification of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, lumacaftor, tezacaftor, elexacaftor, and their major metabolites in hum	12
Digital transformation and sustainability in healthcare and clinical laboratories	12
Identification of macrotroponin T: findings from a case report and non-reproducible troponin T results	12

A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives	12
Complete blood counts and cell population data from Sysmex XN analyser in the detection of SARS-CoV-2 infection	12
Towards 50 years of platelet function analyser (PFA) testing	12
Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection	12
The importance of correct stratifications when comparing directly and indirectly estimated reference intervals	12
Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML	12
Rethinking internal quality control: the time is now	12
Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers	12
Comparison of the reliability of Gram-negative and Gram-positive flags of the Sysmex UF-5000 with manual Gram stain and urine culture results	12
Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma	12
A novel scoring system combining Modified Early Warning Score with biomarkers of monocyte distribution width, white blood cell counts, and neutrophil-to-lymphocyte ratio to improve early sepsis predic	12
Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign	12
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patients	11
Comparison of two LC-MS/MS methods for the quantification of 24,25-dihydroxyvitamin D3 in patients and external quality assurance samples	11
Current performance of C-reactive protein determination and derivation of quality specifications for its measurement uncertainty	11
Lot-to-lot variation: no longer a neglected issue	11
Toolkit for emerging technologies in laboratory medicine	11
Derivation of sex and age-specific reference intervals for clinical chemistry analytes in healthy Ghanaian adults	11
Statistics in diagnostic medicine	11
A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers	11
Critical role of pre-analytical aspects for the measurement of circulating calprotectin in serum or plasma as a biomarker for neutrophil-related inflammation	11
A comprehensive comparison between ISAC and ALEX2 multiplex test systems	11
Clinical performance of calcitonin and procalcitonin Elecsys® immunoassays in patients with medullary thyroid carcinoma	11
ChatGPT: Angel or Demond? Critical thinking is still needed	11
Pre-analytical considerations in biomarker research: focus on cardiovascular disease	11
Deciphering the role of monocyte and monocyte distribution width (MDW) in COVID-19: an updated systematic review and meta-analysis	11
Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LD	11
A highly accurate delta check method using deep learning for detection of sample mix-up in the clinical laboratory	11
Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection	11
Pre-analytical variability of the Lumipulse immunoassay for plasma biomarkers of Alzheimer’s disease	11
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients	11
IgA rheumatoid factor in rheumatoid arthritis	11
Recommendation for the design of stability studies on clinical specimens	11
Individual uromodulin serum concentration is independent of glomerular filtration rate in healthy kidney donors	10
Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma	10
Effect of collection matrix, platelet depletion, and storage conditions on plasma extracellular vesicles and extracellular vesicle-associated miRNAs measurements	10
Tutorial: statistical methods for the meta-analysis of diagnostic test accuracy studies	10
Imperative: reducing the environmental impact of clinical laboratories	10
Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood	10
Does COVID-19 alter the oxyhemoglobin dissociation curve? – An observational cohort study using a mixed-effect modelling	10
Comparison of iohexol plasma clearance formulas vs. inulin urinary clearance for measuring glomerular filtration rate	10
Pooling for SARS-CoV-2-testing: comparison of three commercially available RT-qPCR kits in an experimental approach	10
Clinical lipidomics in the era of the big data	10
Pediatric reference intervals for endocrine markers and fertility hormones in healthy children and adolescents on the Siemens Healthineers Atellica immunoassay system	10
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy	10
Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy	10
Re-examining ferritin-bound iron: current and developing clinical tools	10
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay	10
Biological variation – eight years after the 1st Strategic Conference of EFLM	10
Within- and between-subject biological variation data for serum zinc, copper and selenium obtained from 68 apparently healthy Turkish subjects	10
Addressing standardized definitions of post-COVID and long-COVID	10
A multi-laboratory assessment of congenital thrombophilia assays performed on the ACL TOP 50 family for harmonisation of thrombophilia testing in a large laboratory network	10
Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test	10
What is the impact of circulating histones in COVID-19: a systematic review	10
The successful inclusion of ADA SCID in Tuscany expanded newborn screening program	10
Biological variation of cardiac myosin-binding protein C in healthy individuals	9
Determination of cortisone and cortisol in human scalp hair using an improved LC-MS/MS-based method	9
Identifying predictors of varices grading in patients with cirrhosis using ensemble learning	9
Interpretable machine learning model to detect chemically adulterated urine samples analyzed by high resolution mass spectrometry	9
Point-of-care high-sensitivity troponin-I analysis in capillary blood for acute coronary syndrome diagnostics	9
Turnaround time prediction for clinical chemistry samples using machine learning	9
Annual biological variation and personalized reference intervals of clinical chemistry and hematology analytes	9
Measurement of urine albumin by liquid chromatography-isotope dilution tandem mass spectrometry and its application to value assignment of external quality assessment samples and certification of refe	9
Improving measurement uncertainty of plasma electrolytes: a complex but not impossible task	9
Performance of three automated SARS-CoV-2 antibody assays and relevance of orthogonal testing algorithms	9
Perinatal presepsin assessment: a new sepsis diagnostic tool?	9
Artificial intelligence: is it the right time for clinical laboratories?	9
Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours	9
The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis	9
Overcoming challenges regarding reference materials and regulations that influence global standardization of medical laboratory testing results	9
Reference intervals of 14 biochemical markers for children and adolescence in China: the PRINCE study	9
Identification of contagious SARS-CoV-2 infected individuals by Roche’s Rapid Antigen Test	9
Reference intervals for venous blood gas measurement in adults	9
Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management	9
Which laboratory technique is used for the blood sodium analysis in clinical research? A systematic review	9
Clinical usefulness of circulating tumor markers	9
Development of a certified reference material for anti-β2-glycoprotein I IgG – commutability studies	9
Performance of machine learning techniques on prediction of esophageal varices grades among patients with cirrhosis	9
Differences between high-sensitivity cardiac troponin T and I in stable populations: underlying causes and clinical implications	9
Accurate stratification between VEXAS syndrome and differential diagnoses by deep learning analysis of peripheral blood smears	9
Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score	9
Recommendations for IVDR compliant in-house software development in clinical practice: a how-to paper with three use cases	9
Assessing vitamin D metabolism – four decades of experience	9
Time to address quality control processes applied to antibody testing for infectious diseases	9
Moving average quality control of routine chemistry and hematology parameters – a toolbox for implementation	9
Establishing metrological traceability for small molecule measurands in laboratory medicine	9
Glycated albumin in diabetes mellitus: a meta-analysis of diagnostic test accuracy	9
Machine learning-based system for prediction of ascites grades in patients with liver cirrhosis using laboratory and clinical data: design and implementation study	9
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients	9
Age and sex specific reference intervals of 13 hematological analytes in Chinese children and adolescents aged from 28 days up to 20 years: the PRINCE study	9
How to evaluate fixed clinical QC limits vs. risk-based SQC strategies	8
Urinary exosomal CD26 is associated with recovery from acute kidney injury in intensive care units: a prospective cohort study	8
A proposed Common Training Framework for Specialists in Laboratory Medicine under EU Directive 2013/55/EC (The Recognition of Professional Qualifications)	8
Long-term stability of 25-hydroxyvitamin D: importance of the analytical method and of the patient matrix	8
The chitinases as biomarkers in immune-mediate diseases	8